Lumizyme 5 mg/mL
ALGLUCOSIDASE ALFA · INJECTION, POWDER, FOR SOLUTION · Genzyme Corporation
Lumizyme is a injection, powder, for solution containing alglucosidase alfa at 5 mg/mL, taken intravenous. Manufactured by Genzyme Corporation.
Key Facts
- Brand Name
- Lumizyme
- Generic Name
- ALGLUCOSIDASE ALFA
- NDC Code (Product)
58468-0160- Manufacturer
- Genzyme Corporation
- Strength
- 5 mg/mL
- Dosage Form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125291
- Drug Class
- Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]
- Marketing Start
- 05/24/2010
Recall History
No Recall HistoryFrequently Asked Questions
What is Lumizyme used for?
Lumizyme contains ALGLUCOSIDASE ALFA. It is a injection, powder, for solution taken intravenous. Consult your doctor for specific uses.
Is Lumizyme a controlled substance?
Lumizyme is not classified as a controlled substance by the DEA.
What is the generic name for Lumizyme?
The generic name for Lumizyme is ALGLUCOSIDASE ALFA. There are no other listed brand versions of ALGLUCOSIDASE ALFA.
What is the NDC code for Lumizyme 5 mg/mL?
The NDC (National Drug Code) for Lumizyme 5 mg/mL is 58468-0160, listed by Genzyme Corporation.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)